Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenue $ 1,468 $ 3,616
Cost of revenue 831 2,017
Gross profit 637 1,599
Operating expenses:    
Sales and marketing 2,520 2,809
Research and development 711 1,384
General and administrative 2,187 2,318
Total operating expenses 5,418 6,511
Loss from operations (4,781) (4,912)
Other income (expense), net:    
Interest expense (52) (121)
Gain (loss) on revaluation of warrant liabilities 2,519 (1,122)
Loss on modification of warrant 0 (257)
Other expense, net (220) (139)
Total other income (expense), net 2,247 (1,639)
Net loss (2,534) (6,551)
Other comprehensive income 173 148
Comprehensive loss $ (2,361) $ (6,403)
Basic and diluted net loss per share applicable to common shareholders (in dollars per share) $ (0.44) $ (1.51)
Weighted average number of shares outstanding, basic and diluted (in shares) 5,803 4,338